Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vertex Pharmaceuticals Incorpo - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
VRTX
Nasdaq
2834
https://www.vrtx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vertex Pharmaceuticals Incorpo
Is CRISPR Therapeutics Stock a Buy?
- May 17th, 2024 1:30 pm
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
- May 15th, 2024 3:11 pm
Jennifer Schneider Elected to Vertex Board of Directors
- May 15th, 2024 2:30 pm
Vertex Stock Hit All-Time High, Paused, Rising Again
- May 14th, 2024 5:47 pm
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
- May 14th, 2024 1:45 pm
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
- May 12th, 2024 6:47 pm
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
- May 12th, 2024 4:20 pm
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
- May 10th, 2024 4:46 pm
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
- May 9th, 2024 2:58 pm
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
- May 9th, 2024 1:11 pm
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
- May 9th, 2024 12:11 pm
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
- May 9th, 2024 5:04 am
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
- May 8th, 2024 4:36 pm
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- May 8th, 2024 1:30 pm
Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
- May 8th, 2024 12:30 pm
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
- May 8th, 2024 9:43 am
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
- May 7th, 2024 8:06 pm
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
- May 7th, 2024 3:24 pm
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
- May 7th, 2024 1:50 pm
Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
- May 7th, 2024 7:08 am
Scroll